ABBOTT INDIA
|
The Current P/E Ratio of ABBOTT INDIA is 47.63.
Share Price | ₹32,628.7 | Aug 18,2025 |
Market Cap | ₹69,172.8 Cr | |
Earnings-TTM | ₹1,452.3 Cr | TTM-Standalone Results |
Price/Earnings | 47.63x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of ABBOTT INDIA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹69,172.8 Cr] as on Aug 18,2025
(/) Earnings [ ₹1,452.3 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 47.63x ]
Thus, for ABBOTT INDIA , the investors are currently willing to pay 47.63 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ABBOTT INDIA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ABBOTT INDIA over the last five years.
Historical PE (Price/Earnings) ratio chart of ABBOTT INDIA
PE Ratio Performance Analysis for ABBOTT INDIA
- ABBOTT INDIA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 47.29x.
- ABBOTT INDIA 's operated at median p/e ratio of 47.09x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ABBOTT INDIA 's p/e ratio peaked in Mar2023 at 49.43x.
- ABBOTT INDIA 's p/e ratio hit its five-year low in Mar2021 of 46.11x.
How does ABBOTT INDIA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
ABBOTT INDIA | 1,452.29 | 47.63 | 69,172.8 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 37.62 | 391,667.0 |
DIVIS LABORATORIES LTD | 2,306.00 | 70.99 | 163,697.0 |
CIPLA LTD | 5,406.81 | 23.37 | 126,365.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 61.76 | 123,639.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 18.42 | 105,479.0 |
MANKIND PHARMA LTD | 1,905.51 | 53.50 | 101,942.0 |
ZYDUS LIFESCIENCES LTD | 4,637.80 | 21.40 | 99,270.0 |
LUPIN LTD | 3,722.18 | 24.17 | 89,954.1 |
AUROBINDO PHARMA LTD | 3,417.93 | 18.52 | 63,307.4 |
ALKEM LABORATORIES LTD | 2,334.08 | 27.40 | 63,952.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ABBOTT INDIA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.42x |
Max industry PE | 70.99x |
Median industry PE | 27.40x |
Average industry PE | 36.80x |
You may also like the below Video Courses